Purple Biotech (PPBT) Exchange Rate Effect (2017 - 2026)
Purple Biotech (PPBT) posted quarterly Exchange Rate Effect of -$10000.0 for Q1 2026, up 9.09% year-over-year from -$9166.7 in Q1 2025, and down 900.0% quarter-over-quarter from -$1000.0 in Q4 2025.
Purple Biotech (PPBT) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Exchange Rate Effect for 10 consecutive years, with -$10000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 9.09% year-over-year to -$10000.0; the TTM figure through Mar 2026 stood at $8000.0 (up 161.54% YoY), while the FY2025 annual figure was $7000.0, up 275.0% from the prior year.
- Exchange Rate Effect eased to -$10000.0 in Q1 2026 per PPBT's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $82000.0 in Q4 2022 and bottomed at -$147000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$6625.0 across 5 years, with a median of -$7500.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 5600.0% — and 2025, when it jumped 800.0%.
- Purple Biotech's Exchange Rate Effect stood at $82000.0 in 2022, then plunged by 42.68% to $47000.0 in 2023, then slumped by 93.62% to $3000.0 in 2024, then sank by 133.33% to -$1000.0 in 2025, then plunged by 900.0% to -$10000.0 in 2026.
- Business Quant data shows PPBT's Exchange Rate Effect at -$10000.0 in Q1 2026, -$1000.0 in Q4 2025, and -$16000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Purple Biotech | 130.35 | 130.35 | - | 53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |